P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer

Breast Cancer Research and Treatment

Volumn 42, Issue 1, 1997, Pages 65-72

  Chung, Hyun Cheol ^a   Rha, Sun Young ^a   Kim, Joo Hang ^a   Roh, Jae Kyung ^a   Min, Jin Sik ^a   Lee, Kyung Sik ^a   Kim, Byung Soo ^a   Lee, Kyi Beom ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Breast cancer; Drug response; Induction chemotherapy; p glycoprotein

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; P-GLYCOPROTEIN;

EID: 0031018861     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005739525196     Document Type: Article

References (28)

1. Zucali R, Uslenghi C, Kenda R, Bonadonna G: Natural history and survival of breast cancer treated with radiotherapy followed by radical mastectomy. Cancer 37:1422-1431, 1976
2. Bruckman J, Harris J, Levene M, Chaffey J, Hellman S: Results of treating stage III carcinoma of breast by primary radiation therapy. Cancer 43: 985-993, 1979
3. Chu A, Wood W, Doucette A: Inflammatory breast carcinoma treated by radical radiotherapy. Cancer 45: 2730-2737, 1980
4. Balawajder I, Antich PP, Boland J: An analysis of the role of radiotherapy alone in combination with chemotherapy and surgery in the management of advanced breast carcinoma. Cancer 51: 574-580, 1983
5. Bedwinek J, Rao DV, Perez C, Lee J, Finberg B: Stage III and localized stage IV breast cancer: irradiation alone versus irradiation plus surgery. Int J Radiat Oncol Biol Phys 8: 31-36, 1982
6. Grohn P, Heinonen E, Klefstrom P, Tarkkanen J: Adjuvant post-operative radiotherapy, chemotherapy and immunotherapy in stage III breast cancer. Cancer 54: 670-674, 1984
7. DeLena M, Zucali R, Viganotti G, Valagussa P, Bonadonna G: Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer. Cancer Chemother Pharmacol 1: 53-59, 1978
8. Hortobagyi GN, Ames GR, Buzdar FC, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Rousdahl MM, Fraschini G, McBrides CM, Martin RG, Montague E: Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 62: 2507-2516, 1988
9. Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Gueco M, Bartoli C, Yoldi GC, Zucali R, Rilke F, Andreola S, Silvestrini R, Di Fronzo G, Valagussa P: Primary chemotherapy to avoid mastectomy with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539-1545, 1990
10. Bonadonna G, Valagussa P, Brambilla C, Ferrari L: Pre-operative chemotherapy in operable breast cancer. Lancet 341: 1485, 1993
11. Feldman LD, Hortobagyi GN, Buzdar AV, Ames FC, Blumenschein GR: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581, 1986
12. Schwanz GF, Cantor RI, Biermann WA: Neoadjuvant chemotherapy before definitive treatment for stage III carcinoma of the breast. Arch Surg 122: 1430-1434, 1987
13. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM: The prognostic significance of lymph node metastasis after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 124: 21-25, 1985
14. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multi-drug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265-269, 1987
15. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE: Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: Detection of p-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 7: 415-424, 1989
16. Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of p-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8: 689-704, 1990
17. Ro JS, Sahin A, Ro JY, Fristsche H, Hortobagyi G, Blick M: Immunohistochemical analysis of p-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21: 787-791, 1990
18. Verelle P, Missonnier F, Fonck Y, Feillel V, Dionet C, Kwiatkowski F, Plagne R, Chassagne J: Clinical relevance of immunohistochemical detection of multidrug resistance p-glycoprotein in breast carcinoma. J Natl Cancer Inst 83: 111-116, 1991
19. Linn SC, Giaccone G, van Diest PJ, Blokhuis WMD, van der Valk P, van Kalken CK, Kuiper CM, Pinedo HM, Baak JPA: Prognostic relevance of p-glycoprotein expression in breast cancer. Ann Oncol 6: 679-685, 1995
20. Seymour L, Bezwoda WR, Dansey RD: P-glycoprotein immunostaining correlates with ER and with high Ki67 expression but fails to predict anthracycline resistance in patients with advanced breast cancer. Breast Cancer Res Treat 36: 61-69, 1995
21. Wu YF, Zhen ZA, Shao JK, Zhen HD, Han ZH: Histopathologic effect of preoperative chemotherapy using 5-FU fat emulsion in gastric cancer. J Surg Oncol 29: 50-53, 1985
22. Sheper RJ, Brakkee JGP, Quak JJ, Shoot EV, Balm AJM, Meijer CJLM, Broxterman MJ, Kuiper CH, Lanklema J, Pinedo HM: Monoclonal antibody JSB-1 detects a highly conserved epitope on the p-glycoprotein associated with multidrug resistance. Int J Cancer 42: 389-394, 1988
23. Deuchars KL, Ling V: P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16:156-165, 1989
24. Merkel DE, Fuqua SAW, Tandon AK, Hill SM, Buzdar AU, MacGuire WL: Electrophoretic analysis of 248 clinical breast cancer specimens for p-glycoprotein overexpression or gene amplification. J Clin Oncol 7: 1129-1136, 1989
25. Salmon SE, Grogan TM, Miller T, Scheper R, Dalton WS: Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by p-glycoprotein staining. J Natl Cancer Inst 81: 696-701, 1989
26. Wishart GC, Plumb JA, Going JJ, McNicol AM, McArdle CS, Tsuruo T, Kage SB: P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies. Br J Cancer 62: 758-761, 1990
27. Epstein J, Xiao H, Oba BK: P-glycoprotein expression in plasma-cell myeloma is associated with resistance to VAD. Blood 74: 913-917, 1989
28. Ma DDF, Davey RA, Harman DH, Isbister JP, Scurr RD, Mackertich SM, Dowden G, Bell DR: Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukemia. Lancet 1: 135-137, 1987